While the term FemTech may be unfamiliar to some, there is wide and growing recognition among self-insured employers that are joining the...

In the dynamic field of life sciences, both biological research and AI are coming together to alter our perspective on life at its most...

In recent news, Recursion (NASDAQ: RXRX), a prominent clinical stage TechBio firm, has announced the signing of agreements to acquire...

Data is king in modern biopharmaceutical research, and ability to generate massive amounts of quality biomedical data represents a...

The advent of AI in drug discovery at a glance The current advent of artificial intelligence (AI) is shaping the evolution of entire...

In the early 2000s, the concept of organ-on-a-chip technology, also known as microphysiological systems, emerged as a way to replicate...

Value-based plans are emerging as particularly attractive coverage options for therapies that become available after an FDA accelerated...

As Merck (NYSE:MRK) and Ridgeback Biotherapeutics sign on to a licensing deal to expand global use of their COVID-19 capsule...

By opening a National Coverage Determination (NCD) on Biogen’s (NASDAQ:BIIB) Aduhelm (aducanumab) for Alzheimer’s disease, Medicare has...

Blood cancer oncologists are likely to hold back for now on using Oncopeptides’ (STO:ONCO) Pepaxto (melphalan flufenamide) in...